SCHEMBL202243

SCHEMBL202243

CCCCCCCC/C=C\CCCCCCC(C)C(=O)O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACE2 Q9BYF1 1/20 0.65
TERT O14746 3/20 0.56
PTPN1 P18031 3/20 0.56
PPARG P37231 3/20 0.56
PPARD Q03181 3/20 0.56
PPARA Q07869 3/20 0.56
TOP1 P11387 3/20 0.56
MAPT P10636 2/20 0.56
BLM P54132 2/20 0.56
HSD17B10 Q99714 2/20 0.56
FABP4 P15090 2/20 0.56
GMNN O75496 1/20 0.56
USP2 O75604 1/20 0.56
LMNA P02545 1/20 0.56
CYP1A2 P05177 1/20 0.56
POLB P06746 1/20 0.56
CYP2C9 P11712 1/20 0.56
ALOX15 P16050 1/20 0.56
APEX1 P27695 1/20 0.56
CYP2C19 P33261 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1115986 1.00 ACE2 (0.65) ACE2TERTPTPN1PPARGPPARD
SCHEMBL6432222 1.00 ACE2 (0.65) ACE2TERTPTPN1PPARGPPARD
SCHEMBL1935186 1.00 ACE2 (0.65) ACE2TERTPTPN1PPARGPPARD
SCHEMBL14795751 1.00 ACE2 (0.65) ACE2TERTPTPN1PPARGPPARD
SCHEMBL18955451 1.00 ACE2 (0.65) ACE2TERTPTPN1PPARGPPARD
SCHEMBL6432220 1.00 ACE2 (0.65) ACE2TERTPTPN1PPARGPPARD
SCHEMBL1647193 1.00 ACE2 (0.65) ACE2TERTPTPN1PPARGPPARD
SCHEMBL1647192 1.00 ACE2 (0.65) ACE2TERTPTPN1PPARGPPARD
SCHEMBL14775351 1.00 ACE2 (0.65) ACE2TERTPTPN1PPARGPPARD
SCHEMBL22772992 1.00 ACE2 (0.65) ACE2TERTPTPN1PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260091047-A1 THERAPEUTIC COMBINATIONS FOR MOVEMENT DISORDERS NATIVE CODE BIO LLC (US) 2026-04-02 US claimed
US-12514254-B2 Rosa canina rosehip UNIVERSITA′ DEGLI STUDI DI CAGLIARI (IT) 2026-01-06 US claimed
EP-4583856-A2 THERAPEUTIC COMBINATIONS FOR MOVEMENT DISORDERS Native Code Bio, LLC (US) 2025-07-16 EP claimed
WO-2024054688-A2 THERAPEUTIC COMBINATIONS FOR MOVEMENT DISORDERS NATIVE CODE BIO, LLC (US) 2024-03-14 WO claimed
US-20240041054-A1 ROSA CANINA ROSEHIP UNIVERSITA' DEGLI STUDI DI CAGLIARI (IT) 2024-02-08 US claimed
EP-4294361-A1 ROSEHIP UNIVERSITA' DEGLI STUDI DI CAGLIARI (IT) 2023-12-27 EP claimed
WO-2022136907-A1 ROSEHIP UNIVERSITA' DEGLI STUDI DI CAGLIARI (IT) 2022-06-30 WO claimed
EP-3011041-B1 BIODIESEL COMPOSITION AND RELATED PROCESS AND PRODUCTS ARGENT ENERGY UK LTD (GB) 2020-02-19 EP claimed
CN-103910738-B A kind of Bisbenzylisoquinolincompounds quaternary ammonium salt and preparation method thereof and the application in preparing antitumor drug 山东师范大学 2016-07-06 CN claimed
CN-103910741-B Bisbenzylisoquinolincompounds trimethyl-glycine and preparation method thereof and the application in antitumor drug preparation Shangdong Normal University (CN) 2016-04-13 CN claimed
US-20110136906-A1 USE OF HYDROXYOLEIC ACID AND RELATED COMPOUNDS IN THE MANUFACTURE OF DRUGS UNIVERSITAT DE LES ILLES BALEARS 2011-06-09 US claimed
US-20090082446-A1 Administering to a lung cancer patient 2-hydroxyoleic acid in an amount effective to inhabit proliferation of the cancer; leukemia, brain metastasis UNIVERSITAT DE LES ILLES BALEARS 2009-03-26 US claimed
CN-101259121-A Use of hydroxyoleic acid and similar compounds in the production of medicaments UNIV ILLES BALEARS (ES) 2008-09-10 CN claimed
CN-1901813-A Use of hydroxyoleic acid and related compounds as functional food additives UNIV ILLES BALEARS (ES) 2007-01-24 CN claimed
EP-1696741-A1 USE OF HYDROXYOLEIC ACID AND RELATED COMPOUNDS AS FUNCTIONAL FOOD ADDITIVES Universitat de les Illes Balears (ES) 2006-09-06 EP claimed
EP-1435235-B1 USE OF HYDROXYOLEIC ACID AND SIMILAR COMPOUNDS IN THE PRODUCTION OF MEDICAMENTS UNIV ILLES BALEARS (ES) 2006-04-05 EP claimed
CN-1688302-A Use of hydroxyoleic acid and related compounds in the preparation of medicaments UNIV ILLES BALEARS (ES) 2005-10-26 CN claimed
WO-2005041691-A1 USE OF HYDROXYOLEIC ACID AND RELATED COMPOUNDS AS FUNCTIONAL FOOD ADDITIVES UNIVERSITAT DE LES ILLES BALEARS (ES) 2005-05-12 WO claimed
US-20050014831-A1 Cancer, hypertension, obesity; diseases mediated by alteration of membrane structure and regulation of G-proteins or receptors UNIVERSITAT DES LESS ILLES BALEARS (ES) 2005-01-20 US claimed
EP-1435235-A1 USE OF HYDROXYOLEIC ACID AND SIMILAR COMPOUNDS IN THE PRODUCTION OF MEDICAMENTS Universitat de les Illes Balears (ES) 2004-07-07 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260091047-A1 THERAPEUTIC COMBINATIONS FOR MOVEMENT DISORDERS HMBS, SNCA, PYGB ACE2 4071/4885TERT 2025/4885PTPN1 4587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.